FineMark National Bank & Trust Buys New Stake in HCA Healthcare, Inc. (NYSE:HCA)

FineMark National Bank & Trust acquired a new position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The firm acquired 3,594 shares of the company's stock, valued at approximately $973,000.

A number of other large investors have also recently made changes to their positions in HCA. Norges Bank purchased a new position in shares of HCA Healthcare in the 4th quarter valued at approximately $694,985,000. Northern Trust Corp lifted its stake in shares of HCA Healthcare by 3.2% in the 3rd quarter. Northern Trust Corp now owns 2,152,419 shares of the company's stock valued at $529,452,000 after purchasing an additional 67,332 shares during the period. Morgan Stanley raised its stake in HCA Healthcare by 1.4% during the third quarter. Morgan Stanley now owns 2,150,009 shares of the company's stock valued at $528,860,000 after buying an additional 30,072 shares during the last quarter. Invesco Ltd. raised its stake in HCA Healthcare by 5.0% during the third quarter. Invesco Ltd. now owns 2,146,844 shares of the company's stock valued at $528,081,000 after buying an additional 102,025 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. raised its stake in HCA Healthcare by 0.6% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,126,550 shares of the company's stock valued at $304,935,000 after buying an additional 6,407 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

HCA has been the subject of a number of recent research reports. Deutsche Bank Aktiengesellschaft lifted their price objective on HCA Healthcare from $330.00 to $359.00 and gave the company a "buy" rating in a research note on Friday, April 12th. Truist Financial lifted their target price on HCA Healthcare from $320.00 to $345.00 and gave the stock a "buy" rating in a report on Wednesday, January 31st. Oppenheimer lifted their target price on HCA Healthcare from $330.00 to $345.00 and gave the stock an "outperform" rating in a report on Monday, April 29th. Barclays lifted their target price on HCA Healthcare from $356.00 to $367.00 and gave the stock an "overweight" rating in a report on Monday, April 29th. Finally, Wells Fargo & Company lifted their target price on HCA Healthcare from $303.00 to $315.00 and gave the stock an "equal weight" rating in a report on Thursday, March 28th. Four research analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $317.00.

Insider Activity

In related news, EVP Michael S. Cuffe sold 1,600 shares of the business's stock in a transaction dated Monday, May 6th. The stock was sold at an average price of $309.00, for a total value of $494,400.00. Following the sale, the executive vice president now directly owns 34,124 shares in the company, valued at $10,544,316. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In other HCA Healthcare news, SVP Chad J. Wasserman sold 344 shares of the company's stock in a transaction that occurred on Monday, March 18th. The stock was sold at an average price of $321.97, for a total transaction of $110,757.68. Following the sale, the senior vice president now directly owns 2,452 shares in the company, valued at $789,470.44. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Michael S. Cuffe sold 1,600 shares of the company's stock in a transaction that occurred on Monday, May 6th. The shares were sold at an average price of $309.00, for a total value of $494,400.00. Following the sale, the executive vice president now owns 34,124 shares in the company, valued at $10,544,316. The disclosure for this sale can be found here. Insiders have sold 13,617 shares of company stock worth $4,321,986 over the last ninety days. Corporate insiders own 1.60% of the company's stock.

HCA Healthcare Stock Performance

NYSE:HCA traded up $3.38 during mid-day trading on Friday, hitting $318.70. 814,302 shares of the company traded hands, compared to its average volume of 994,269. The stock's fifty day moving average price is $318.89 and its 200-day moving average price is $305.81. HCA Healthcare, Inc. has a one year low of $215.96 and a one year high of $335.83. The company has a quick ratio of 1.02, a current ratio of 1.16 and a debt-to-equity ratio of 29.26. The firm has a market cap of $83.47 billion, a price-to-earnings ratio of 15.89, a price-to-earnings-growth ratio of 1.46 and a beta of 1.66.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings data on Friday, April 26th. The company reported $5.36 EPS for the quarter, beating the consensus estimate of $5.01 by $0.35. HCA Healthcare had a return on equity of 674.49% and a net margin of 8.20%. The business had revenue of $17.34 billion for the quarter, compared to the consensus estimate of $16.81 billion. During the same period in the previous year, the business earned $4.93 earnings per share. The business's revenue was up 11.2% on a year-over-year basis. Research analysts anticipate that HCA Healthcare, Inc. will post 20.84 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, June 28th. Stockholders of record on Friday, June 14th will be given a $0.66 dividend. The ex-dividend date of this dividend is Friday, June 14th. This represents a $2.64 annualized dividend and a dividend yield of 0.83%. HCA Healthcare's payout ratio is 13.16%.

HCA Healthcare declared that its board has approved a share repurchase plan on Tuesday, January 30th that allows the company to buyback $6.00 billion in outstanding shares. This buyback authorization allows the company to reacquire up to 7.4% of its shares through open market purchases. Shares buyback plans are typically an indication that the company's board believes its stock is undervalued.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.